0001209191-15-063890.txt : 20150805 0001209191-15-063890.hdr.sgml : 20150805 20150805085908 ACCESSION NUMBER: 0001209191-15-063890 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150805 DATE AS OF CHANGE: 20150805 EFFECTIVENESS DATE: 20150805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AYTU BIOSCIENCE, INC CENTRAL INDEX KEY: 0001385818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 470883144 STATE OF INCORPORATION: CO FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-245095 FILM NUMBER: 151027621 BUSINESS ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (720) 437-6580 MAIL ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 200 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC. DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: Rosewind CORP DATE OF NAME CHANGE: 20070110 D 1 primary_doc.xml X0707 D LIVE 0001385818 AYTU BIOSCIENCE, INC 373 Inverness Parkway Suite 200 Englewood CO COLORADO 80112 720-437-6580 COLORADO Rosewind Corporation AYTU BIOSCIENCE, INC. Rosewind CORP Corporation true Joshua R. Disbrow c/o AytuBioscience, Inc. 373 Inverness Parkway, Suite 200 Englewood CO COLORADO 80112 Executive Officer Jarrett T. Disbrow c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 200 Englewood CO COLORADO 80112 Executive Officer Gregory A. Gould c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 200 Englewood CO COLORADO 80112 Executive Officer Michael Macaluso c/o Aytu Bioscience, Inc. 373 Inverness Parkway, Suite 200 Englewood CO COLORADO 80112 Director Pharmaceuticals Decline to Disclose 06b false 2015-07-22 false true false 0 Newbridge Securities Corporation 104065 None None 1451 Cypress Creek Road, Suite 204 Ft. Lauderdale FL FLORIDA 33309 All States 6000000 2010000 3990000 false 20 128000 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. false Aytu Bioscience, Inc /s/ Gregory A. Gould Gregory A. Gould Chief Financial Officer 2015-07-31